Jim Simons Ovid Therapeutics Inc. Transaction History

Renaissance Technologies LLC

$56.7 Billion
Q2 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 141,200 shares of OVID stock, worth $192,032. This represents 0.0% of its overall portfolio holdings.

Number of Shares

141,200

Previous 156,800 9.95%

Holding current value

$192,032

Previous $478,000 77.41%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$0.7 - $3.34 $10,920 - $52,104	-15,600 Reduced 9.95%	141,200 $108,000
Q1 2024 May 13, 2024	BUY	$2.72 - $4.04 $287,232 - $426,624	105,600 Added 206.25%	156,800 $478,000
Q4 2023 Feb 13, 2024	SELL	$2.98 - $3.78 $88,208 - $111,888	-29,600 Reduced 36.63%	51,200 $165,000
Q3 2023 Nov 14, 2023	SELL	$3.23 - $3.97 $109,497 - $134,583	-33,900 Reduced 29.56%	80,800 $310,000
Q2 2023 Aug 11, 2023	SELL	$2.53 - $3.89 $14,926 - $22,951	-5,900 Reduced 4.89%	114,700 $376,000
Q1 2023 May 12, 2023	BUY	$1.88 - $2.85 $1,504 - $2,280	800 Added 0.67%	120,600 $311,000
Q4 2022 Feb 13, 2023	BUY	$1.43 - $1.89 $1,430 - $1,890	1,000 Added 0.84%	119,800 $223,000
Q3 2022 Nov 14, 2022	SELL	$1.84 - $2.26 $9,200 - $11,299	-5,000 Reduced 4.04%	118,800 $219,000
Q2 2022 Aug 12, 2022	BUY	$1.69 - $3.31 $65,910 - $129,090	39,000 Added 45.99%	123,800 $266,000
Q1 2022 May 13, 2022	BUY	$2.65 - $3.49 $69,430 - $91,438	26,200 Added 44.71%	84,800 $266,000
Q4 2021 Feb 11, 2022	BUY	$3.13 - $3.73 $75,433 - $89,893	24,100 Added 69.86%	58,600 $188,000
Q3 2021 Nov 12, 2021	BUY	$3.31 - $4.04 $114,195 - $139,380	34,500 New	34,500 $116,000
Q1 2021 May 13, 2021	SELL	$2.42 - $4.47 $1.72 Million - $3.18 Million	-710,507 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$2.28 - $6.84 $1.62 Million - $4.86 Million	710,507 New	710,507 $1.64 Million
Q3 2020 Nov 13, 2020	SELL	$5.39 - $8.24 $3.36 Million - $5.14 Million	-624,109 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$2.67 - $7.91 $610,719 - $1.81 Million	-228,734 Reduced 26.82%	624,109 $4.6 Million
Q1 2020 May 14, 2020	SELL	$2.03 - $4.35 $470,687 - $1.01 Million	-231,866 Reduced 21.38%	852,843 $2.54 Million
Q4 2019 Feb 13, 2020	BUY	$2.08 - $5.06 $1.04 Million - $2.52 Million	497,984 Added 84.88%	1,084,709 $4.5 Million
Q3 2019 Nov 13, 2019	BUY	$1.76 - $3.51 $202,604 - $404,057	115,116 Added 24.41%	586,725 $1.9 Million
Q2 2019 Aug 12, 2019	BUY	$1.59 - $2.14 $172,343 - $231,958	108,392 Added 29.84%	471,609 $872,000
Q1 2019 May 14, 2019	BUY	$1.77 - $3.56 $545,367 - $1.1 Million	308,117 Added 559.2%	363,217 $643,000
Q4 2018 Feb 13, 2019	BUY	$2.42 - $6.6 $133,342 - $363,660	55,100 New	55,100 $133,000

Others Institutions Holding OVID

# of Institutions

Shares Held

39.3M

Call Options Held

10.3K

Put Options Held

200

View Full List

About Ovid Therapeutics Inc.

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $95.8M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

More about OVID

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account